Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How safe and effective is surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 490–491 (2007)Cite this article

boxed-textMurphy EM et al. (2007) Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 50: 37–42

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Carmignani P et al. (2003) sIntraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer Metastasis Rev 22: 465–472

    Article  Google Scholar 

  2. Sugarbaker PH (2006) New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome. Lancet Oncol 7: 69–76

    Article  Google Scholar 

  3. Sugarbaker PH et al. (2006) Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13: 635–644

    Article  Google Scholar 

  4. Levine EA et al. (2007) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg 204: 94–953

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Washington Cancer Institute, Suite 3900, 106 Irving St NW, Washington, DC 20010, USA Paul.Sugarbaker@medstar.net

Authors and Affiliations

  1. PH Sugarbaker is Director of the Peritoneal Surface Malignancy Program at the Washington Cancer Institute, Washington, DC, USA.,

    Paul H Sugarbaker

Authors
  1. Paul H Sugarbaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugarbaker, P. How safe and effective is surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei?. Nat Rev Gastroenterol Hepatol 4, 490–491 (2007). https://doi.org/10.1038/ncpgasthep0903

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0903

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing